Die Therapie der pulmonal-arteriellen Hypertonie bei COPD ist sinnvoll - contra

pulmonal-arterielle Hypertonie - COPD - Endothelin-Antagonisten - Prostacyclin-Analoga - Phosphodiesterase-Inhibitoren

pulmonary hypertension - COPD - endothelin antagonists - prostacyclin analogues - phosphodiesterase inhibitors

Literatur

• 1 Gassner A. et al . Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Hemodynamic effects of nifedipine, diltiazem and verapamil.  Chest. 1990;  98 829-34
• 2 Rietema H. et al . Long-term effect of sildenafil on exercise capacity in COPD patients.  Eur Resp J. 2007;  30 A 3581
• 3 Sliwinski, P. et al . Acute effect of oxygen on pulmonary arterial pressure does not predict survival on long-term oxygen therapy in patients with chronic obstructive pulmonary disease.  Am Rev Respir Dis. 1992;  146 665-669
• 4 Stolz D. et al . Pulmonary vasodilator therapy in severe COPD: a double-blind, placebo-controlled trial.  Eur Resp J. 2007;  30 A 3164